| ADR Ontology |
| ADR Term |
Eczema infantile |
| ADR ID |
BADD_A09847 |
| ADR Hierarchy |
|
| Description |
A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH] |
| MedDRA Code |
10014198 |
| MeSH ID |
D003876
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Eczema infantile | Infantile eczema | Dermatitis, Atopic | Atopic Dermatitides | Atopic Dermatitis | Dermatitides, Atopic | Neurodermatitis, Atopic | Atopic Neurodermatitides | Atopic Neurodermatitis | Neurodermatitides, Atopic | Neurodermatitis, Disseminated | Disseminated Neurodermatitides | Disseminated Neurodermatitis | Neurodermatitides, Disseminated | Eczema, Atopic | Atopic Eczema | Eczema, Infantile | Infantile Eczema |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D02450 | Crisaborole | 0.000993% | |
| The 1th Page 1
Total 1 Pages
|
|
